NEW YORK, July 14, 2026, 18:07 EDT
- Arbe finished at $0.874, gaining 27.02%. Volume hit 10.73 million shares, close to 4.5 times its average.
- The surge tacked on about $22.8 million in equity value, which is over four times Arbe’s 2026 revenue guidance midpoint.
- Arbe has signed a defense deal for three projects, with some orders already in and deliveries started, but didn’t say who the customer is or give a contract amount.
Arbe Robotics Ltd. NASDAQ:ARBE popped 27.0% Tuesday after saying a global defense integrator picked its radar for three projects. That move added about $22.8 million in market value before Arbe named any amount for the deal. Shares finished at 87.4 cents, trading their busiest day in months. The market moved fast to price in a big win.
The size of the move stands out. Arbe’s last backlog was $1 million; its 2026 revenue target is $4 million to $6 million. Shares added a market cap roughly 22.8 times that backlog, and 4.6 times the $5 million midpoint in sales guidance. Those are basic size comparisons, not standard valuation multiples. Investors seem to be betting on more deals to come.
Arbe will be the exclusive radar supplier under a framework agreement that sets terms but doesn’t lock in a sales figure. The company said it’s already booked initial orders and shipped the first units, with more orders likely in 2026 and 2027. CEO Ram Machness called it “an important step in Arbe’s expansion into high-value verticals beyond automotive.” Timing could be key. Arbe Robotics Ltd.
Innoviz Technologies Ltd. NASDAQ:INVZ, another lidar maker, disclosed on the same day that it’s rolling out Perciz, a brand focusing on defense and homeland security clients. CEO Omer Keilaf said Perciz would help systems “perceive and understand the world around them.” The company did not say how much the new orders are worth. Innoviz Technologies Ltd.
| Asset | Tuesday close | Daily move | Volume versus average | Same-day disclosure |
|---|---|---|---|---|
| Arbe Robotics Ltd. NASDAQ:ARBE | $0.874 | +27.02% | Roughly 4.5 times normal | Outlined three-project plan; reported first orders and deliveries |
| Innoviz Technologies Ltd. NASDAQ:INVZ | $0.628 | +7.46% | About 0.4 times usual | Unveiled dedicated defense business |
| Nasdaq Composite | 26,107.01 | +0.90% | — | Tech market gauge |
| Russell 2000 | 2,964.76 | +0.39% | — | Small-cap barometer |
Arbe’s jump was 3.6x Innoviz’s, and its trading volume was well above normal, while Innoviz volume lagged its average. This points to traders caring more about existing orders and delivered systems than a new entry news hit. One day doesn’t prove contract economics. The difference was clear.
Arbe’s operating metrics set some context for the one-day move:
| Scale comparison | Amount | Tuesday value gain as a multiple |
|---|---|---|
| Market cap added in one day (est.) | $22.8 million | 1.0x |
| Previous backlog reported | $1.0 million | 22.8x |
| 2026 sales estimate, midpoint | $5.0 million | 4.6x |
| 2026 sales estimate, high end | $6.0 million | 3.8x |
The math works off Arbe’s disclosed price jump and 122.65 million shares out. Market value isn’t the same as sales or backlog, but this comparison gives a sense of just how big the expectations are in the stock now. It’s about the size here.
The $22.8 million gain in value on Tuesday topped the $18.5 million Arbe pulled in from its January share sale. Still, shares were 37.6% under the $1.40 a share price from that deal by the close. So the rebound added more to valuation than the cash raise, but didn’t push shares back to that financing level.
Arbe said it held $53.6 million in cash, cash equivalents and short-term deposits as of March 31. The company stuck with its full-year adjusted EBITDA loss outlook of $28 million to $31 million. Adjusted EBITDA removes certain non-cash items and one-offs. No changes to that guidance were part of Tuesday’s release. Cash may buy some time, but it’s not evidence.
The deal may not lead to big sales as soon as some investors are hoping. Arbe didn’t say how many units, who the buyer is, or how much the contract is worth. Shares finished at 87.4 cents, still under Nasdaq’s $1 minimum. Arbe got a price deficiency notice on April 13. It has until October 12 to get the stock back above $1, or it could face delisting. There’s a possible 180-day extension or a reverse split if it comes to that. Investors want real numbers.
If the rally is going to last, later filings have to show the projects moving into revenue, backlog or a raised forecast. Right now, what traders saw Tuesday is more a bet on conversion than a direct read from announced contract values. That’s an important difference.
